WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Dr. Neela Navya, Dr. Ramya Priya Talluri, Dr. Sai Prasanna, Dr. MD Muzaffar Pasha, Dr. M. Prathibha* and Dr. M. V. Rambabu


Background: Comorbidity is the presence of one or more additional diseases or disorders co-occurring with a primary disease or disorder. Quality of life (QoL) incorporates the patient’s perspective of his/her physical, mental and social well-being. Comorbidities can have profound effects on patient’s ability to manage their self-care and pose significant barriers to lifestyle changes and regimen adherence and associated with worse health outcomes, more complex clinical management, and increased health care costs. Hospitalization and subsequent discharge home often involve discontinuity of care, multiple changes in medication regimens, and inadequate patient education regarding the instruction of drug use, respiratory devices, and disease information and also lack of information about the drug's side effects that can lead to medication nonadherence and low level of treatment satisfaction[1], which in turn shows effects on QoL of patient. Aim and Objectives: To assess QoL and Medication Adherence in patients with chronic comorbid conditions using SF-12 questionnaire and Morisky scale respectively. To counsel patients based on their conditions and assess the improvement in their QoL for three months. To use different measures (PIL's, Flash cards) to improve Medication Adherence. To analyze prescriptions for medication errors and suggest suitable recommendations. Methodology: A Prospective Observational study conducted in multispeciality tertiary care hospital with a sample size of 100 patients for a period of 6 months. Patients were recruited based on inclusion and exclusion criteria. Data was collected from the patient by data collection forms and by providing questionnaire. Results and Discussion: The present study, was aimed at assessing quality of life and medication adherence in chronic comorbid conditions (primary conditions: HTN, CVA, CLD, CKD, CAD). In our study QOL was assessed by providing SF-12 questionaires to the patient and the outcomes were observed. QOL was increased by 23.4% in hypertensive patients, 24.24% in CVA patients; 23.51% in CLD patients; 24.36% in CKD patients and 22.66% in CAD patients. Medication adherence was assessed by morisky scale. Means of motivational score was increased by 1.01 & knowledge score was increased by 1.43. Conclusion: Based on our study, we have observed that, Quality of life was poor in CKD patients, when compared to other primary conditions, which was 60.53%, through SF-12 questionaires. After the follow ups, it was increased by 24.36% in CKD patients. Also, an increase in QOL was found in all the conditions. Improvement was also found in medication adherence.

Keywords: Quality of life; Medication adherence; Chronic comorbidities; Hypertension; Cardiovascular accident; Chronic liver disease; Chronic kidney disease; Coronary artery disease; SF-12 quesstioneries; Morisky scale.

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More